BRIEF-Melar Acquisition Says Announces IPO Pricing Of 15 mln shares at $10 per share-February 2024-www.financetom.com

BRIEF-Melar Acquisition Says Announces IPO Pricing Of 15 mln shares at $10 per share

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Melar Acquisition Says Announces IPO Pricing Of 15 mln shares at $10 per share

Jun 17, 2024 4:27 PM

June 17 (Reuters) -

* MELAR ACQUISITION CORP. I ANNOUNCES PRICING OF $150

MILLION

INITIAL PUBLIC OFFERING

* MELAR ACQUISITION - PRICING OF ITS INITIAL PUBLIC OFFERING

OF 15

MILLION UNITS AT $10.00 PER UNIT

Source text for Eikon:

Further company coverage:

Previous page： --Rayonier Keeps Quarterly Dividend of $0.285 a Share, Payable Dec. 31 to Shareholders as of Dec. 17 Next page： --Highwoods Properties Keeps Quarterly Dividend at $0.50 per Share, Payable Dec. 10 to Holders of Record Nov. 18

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Rayonier Keeps Quarterly Dividend of $0.285 a Share, Payable Dec. 31 to Shareholders as of Dec. 17

Oct 21, 2024

10:46 AM EDT, 10/21/2024 (MT Newswires) -- Price: 31.98, Change: -0.38, Percent Change: -1.17 ...

--Highwoods Properties Keeps Quarterly Dividend at $0.50 per Share, Payable Dec. 10 to Holders of Record Nov. 18

Oct 21, 2024

10:30 AM EDT, 10/21/2024 (MT Newswires) -- Price: 36.15, Change: -0.22, Percent Change: -0.60 ...

Arcutis Biotherapeutics' Zoryve Approved to Treat Seborrheic Dermatitis in Canada

Oct 21, 2024

10:47 AM EDT, 10/21/2024 (MT Newswires) -- Arcutis Canada, a subsidiary of Arcutis Biotherapeutics ( ARQT ) , said Monday it has received approval from Health Canada for Zoryve to treat seborrheic dermatitis in patients aged 9 and older. Trial data showed notable improvement in signs and symptoms, with the majority of patients experiencing reduced itching, scaling and redness, common...

Why Baidu Stock Is Falling

Oct 21, 2024

Shares of Baidu Inc ( BIDU ) fell 2.7% to $91.78 Monday morning in response to China's decision to cut interest rates, a move intended to stimulate economic growth but instead raised concerns among investors. The rate cut, while typically seen as a positive step to encourage borrowing and spending, failed Monday to reassure markets amid broader concerns about China's...